Object-Oriented Specification of Complex Bio-computing Processes: A Case Study of a Network of Proteolytic Enzymes
暂无分享,去创建一个
[1] Ivar Jacobson,et al. The Unified Modeling Language User Guide , 1998, J. Database Manag..
[2] Bruce Powell Douglass,et al. Real-time UML (2nd ed.): developing efficient objects for embedded systems , 1997 .
[3] K Fujikawa,et al. The coagulation cascade: initiation, maintenance, and regulation. , 1991, Biochemistry.
[4] R. Chambers,et al. Coagulation cascade proteases and tissue fibrosis. , 2001, Biochemical Society transactions.
[5] Bruce Powel Douglass. Real-Time UML , 2002, FTRTFT.
[6] Paul Woolley,et al. Mechanisms in blood coagulation fibrinolysis and the complement system , 1991 .
[7] S. D. Kimball,et al. Thrombin active site inhibitors. , 1995, Bioorganic & medicinal chemistry.
[8] G. Broze,et al. Tissue factor pathway inhibitor and the revised theory of coagulation. , 1995, Annual review of medicine.
[9] Kendall Scott,et al. UML distilled - a brief guide to the Standard Object Modeling Language (2. ed.) , 2000, notThenot Addison-Wesley object technology series.
[10] Barbara Liskov,et al. Keynote address - data abstraction and hierarchy , 1988, OOPSLA '87.
[11] Amir Pnueli,et al. Formal Modeling of C. elegans Development: A Scenario-Based Approach , 2003, CMSB.
[12] Barbara Liskov,et al. Data Abstraction and Hierarchy , 1987 .
[13] M. Boffa,et al. A Study of the Mechanism of Inhibition of Fibrinolysis by Activated Thrombin-activable Fibrinolysis Inhibitor* , 1998, The Journal of Biological Chemistry.
[14] Jozef Arnout,et al. Anti-factor VIII antibodies of hemophiliac patients are frequently directed towards nonfunctional determinants and do not exhibit isotypic restriction. , 1993 .